Tags: BCL2 inhibitors
Are Novel Agents Ready to Assume the Mantle in the Frontline Treatment of Mantle Cell Lymphoma?
Abstract: Although chemotherapy has been a mainstay of the frontline treatment of mantle cell lymphoma (MCL) for many years, novel agents—including Bruton kinase inhibitors, immunomodulatory agents, […]